Depakote-ER for Depressive and Bipolar Depression
NCT00226343
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Bipolar Disorder
Interventions
DRUG:
Depakote-ER
Sponsor
Cambridge Health Alliance
Collaborators
[object Object]